StockData
Myomo, Inc. logo

Myomo, Inc. (MYO) stock

MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.88−0.04 (-4.23%)

Close on Nov 18, 2026Market cap $34.85MP/E –Yield –

Earnings

Myomo's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 8, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$12.30M
+21.8% on a year earlier
EPS, Q3 FY2026
-$0.10
-$0.09 a year earlier
Latest guidance
Issued
Nov 9, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Myomo's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 8, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close$12.30M+21.8%-$0.10Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close$11.70M+20.6%-$0.09Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close––-$0.07Release
Q4 FY2025ended Dec 31, 2025Mar 9, 2026after the close$11.40M-5.8%-$0.09Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025after the close$10.10M+9.8%-$0.09Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025after the close$9.70M+29.3%-$0.11Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close$9.80M+157.9%-$0.08Release
Q4 FY2024ended Dec 31, 2024Mar 10, 2025after the close$12.10M+152.1%-$0.01Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024after the close$9.20M+80.4%-$0.03Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024after the close$7.50M+25.0%-$0.03Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$3.80M+11.8%-$0.10Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Myomo's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
full year revenue guidanceFY2026$45.00M – $47.00M$43.00M – $46.00MRaisedAug 5, 2026
revenueFY2026$46.00M – $47.00M–NewNov 9, 2026

Guidance vs results

The last range Myomo gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$11.50M – $12.00M$12.30MAbove range
Q3 FY2026Revenue growth+14% – +19%+21.78%Above range
Q2 FY2026Revenue$10.30M – $10.80M$11.70MAbove range
FY2025Revenue$40.00M – $42.00M$41.00MΣ4QWithin range
Q3 FY2025Revenue$9.50M – $10.00M$10.10MAbove range
Q2 FY2025Revenue$9.00M – $9.50M$9.70MAbove range
Q1 FY2025Revenue$9.00M – $9.50M$9.80MAbove range
Q4 FY2024Revenue$9.50M – $10.50M$12.10MAbove range
Q3 FY2024Revenue$8.00M – $8.50M$9.20MAbove range
Q2 FY2024Revenue$5.00M$7.50MAbove range
Q1 FY2024Revenue$4.10M – $4.30M$3.80MBelow range
Q1 FY2023Revenue growth+15% – +20%-12.82%Below range

Guidance history

Every forecast Myomo put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026revenueFY2026$46.00M – $47.00MNew
Aug 5, 2026revenue guidanceover the prior year+10% – +15%–
Aug 5, 2026full year revenue guidanceFY2026$45.00M – $47.00MRaised
Aug 5, 2026revenueQ3 FY2026+14% – +19%New
Aug 5, 2026revenueQ3 FY2026$11.50M – $12.00MNew
May 7, 2026revenueFY2026$43.00M – $46.00MReaffirmed
May 7, 2026revenueQ2 FY2026$10.30M – $10.80MNew
Mar 9, 2026revenueFY2026$43.00M – $46.00MNew
Mar 9, 2026revenueQ1 FY2026$9.00M – $9.50MNew
Nov 10, 2025revenueFY2025$40.00M – $42.00MNew
Aug 11, 2025RevenueQ3 FY2025$9.50M – $10.00MNew
Aug 11, 2025revenue guidanceFY2025$40.00M – $42.00MLowered
May 7, 2025revenueQ2 FY2025$9.00M – $9.50MNew
May 7, 2025revenueFY2025+54% – +63%New
May 7, 2025revenueFY2025$50.00M – $53.00MReaffirmed
Mar 10, 2025RevenueFY2025$50.00M – $53.00MNew
Mar 10, 2025revenueQ1 FY2025$9.00M – $9.50MNew
Nov 6, 2024full year revenueFY2024$30.00M – $31.00MRaised
Nov 6, 2024fourth quarter revenueQ4 FY2024$9.50M – $10.50MNew
Aug 6, 2024revenueFY2024$28.00M – $30.00MReaffirmed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Myomo filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Update
  6. Results
  7. Results
  8. Results
  9. Update
  10. Results
  11. Update
  12. Results
  13. News
  14. News
  15. Results

See a number that looks wrong?